An update of laparoscopy in cervical cancer staging: is it a useful procedure?

Abstract:

OBJECTIVE:It was the aim of this study to report on the role of laparoscopic staging in a large series of locally advanced cervical cancer (LACC) patients and its impact on prognosis. METHODS:Consecutive patients with LACC were considered for surgical staging: gynecological examination, cystoscopy and laparoscopy with peritoneal biopsies and peritoneal fluid cytology. RESULTS:Between February 2000 and September 2010, a total of 167 women were evaluated. In 5 patients, laparoscopy could not be performed. One hundred and sixty-two patients had correct laparoscopic staging: 49 International Federation of Gynecology and Obstetrics (FIGO) stage IB-IIA (>4 cm), 67 IIB, 39 III, and 7 IVA. Abdominal spread was found in 33 cases (20%). There was a minor laparoscopy complication rate of 1%. We found a significant difference in the distribution of peritoneal spread for tumor grade and FIGO stage (p = 0.01 and p < 0.0001, respectively), whereas no statistically significant difference for the histological type was found [p = not significant (NS)]. The median follow-up was 80 months (range 4-144). The median overall survival was 65 months. The patients without abdominal spread did not benefit from a significantly longer survival (median overall survival of 59 vs. 70 months; p = NS). CONCLUSIONS:Laparoscopic staging in cervical cancer is a safe and feasible technique but it does not modify the prognosis of LACC patients.

journal_name

Oncology

journal_title

Oncology

authors

Benedetti Panici P,Perniola G,Tomao F,Fischetti M,Savone D,Di Donato V,Angioli R,Muzii L

doi

10.1159/000351995

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

160-5

issue

3

eissn

0030-2414

issn

1423-0232

pii

000351995

journal_volume

85

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Energy status in HeLa cells after treatment with an arresting anticancer drug.

    abstract::The energy status of HeLa cells arrested in the G2 phase of the cell cycle by the antineoplastic agent cis-acid was compared with that of normal G2-phase-synchronized cells. The results showed that treatment with the drug has significantly decreased the adenylate pool, adenylate energy charge and phosphorylation poten...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226444

    authors: Al-Awadi FM,Al-Bader AA

    更新日期:1987-01-01 00:00:00

  • Colorectal Cancer with BRAF D594G Mutation Is Not Associated with Microsatellite Instability or Poor Prognosis.

    abstract:OBJECTIVE:BRAF D594G mutations in colorectal cancer patients are not clearly understood. We retrospectively investigated the clinicopathological features of colorectal cancers with BRAF D594G mutations. METHODS:We selected 908 colorectal cancer patients who underwent surgical resection from January 2008 to January 201...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000447402

    authors: Amaki-Takao M,Yamaguchi T,Natsume S,Iijima T,Wakaume R,Takahashi K,Matsumoto H,Miyaki M

    更新日期:2016-01-01 00:00:00

  • Effects of combined therapies with protein-bound polysaccharide (PSK, Krestin) and fluorinated pyrimidine derivatives on experimental liver metastases and on the immunologic capacities of the hosts.

    abstract::An experimental model is introduced for the study of liver metastases using intrasplenically injected EL-4 and Lewis lung tumor cells. Fluorinated pyrimidine derivatives, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil, showed inhibitory effects on the frequencies of liver metastases. Immunosuppressive effects...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226989

    authors: Tsuru S,Shinomiya N,Katsura Y,Gotoh M,Noritake M,Nomoto K

    更新日期:1991-01-01 00:00:00

  • Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses.

    abstract:OBJECTIVES:Calcitriol, 1alpha,25-dihydroxyvitamin D(3) (1,25-D(3)) has potent antiproliferative effects and potentiates the antitumor activity of many other cytotoxic drugs. 1,25-D(3) plasma pharmacokinetic (PK) parameters associated with antitumor activity in experimental animal models are unknown. The objective of th...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000076336

    authors: Muindi JR,Modzelewski RA,Peng Y,Trump DL,Johnson CS

    更新日期:2004-01-01 00:00:00

  • The Role of Adjuvant Radiation Therapy for Locoregionally Advanced Papillary Thyroid Carcinoma.

    abstract:OBJECTIVES:To investigate the role of adjuvant radiation therapy in locoregional control in patients with locoregionally advanced papillary thyroid carcinoma (pT4 or pN1b) based on a comparison of a group that received radiation therapy and a group that did not receive radiation therapy. METHODS:A retrospective analys...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000444393

    authors: Lee NK,Kim CY,Baek SK,Jung KY

    更新日期:2016-01-01 00:00:00

  • Synchronous Hodgkin's disease and gastric adenocarcinoma.

    abstract:BACKGROUND:Adenocarcinoma is the most frequent pathological type of stomach cancer. Hodgkin's lymphoma is a lymphoproliferative disease arising from lymphoid tissue which is characterized by Reed-Sternberg cells. Synchronous occurrence of these two malignancies has not been reported in the English literature so far. C...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000136799

    authors: Comez G,Pehlivan Y,Kalender ME,Sevinc A,Sari I,Camci C

    更新日期:2007-01-01 00:00:00

  • A dose escalation study of pegylated liposomal Doxorubicin (caelyx) in combination with capecitabine (xeloda) in patients with refractory solid tumors.

    abstract:OBJECTIVE:Pegylated liposomal doxorubicin (PLD) and capecitabine (CAP) have separately shown significant antitumor activity in a wide range of solid tumors. A phase I study was conducted in order to determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLTs) of their combination in patients with refr...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000090494

    authors: Maltezos E,Amarantidis K,Trichas M,Vasiliadis M,Toromanidou M,Chatzaki E,Karayiannakis A,Tsaroucha A,Romanidis K,Kakolyris S

    更新日期:2005-01-01 00:00:00

  • Expression of the high-affinity fluoropyrimidine-preferring nucleoside transporter hCNT1 correlates with decreased disease-free survival in breast cancer.

    abstract:PURPOSE:Nucleoside and nucleobase derivatives are currently used in the treatment of a variety of solid tumors; however, the role of plasma membrane transporters as biomarkers of drug metabolism has not been fully addressed. Thus, the purpose of this study was to determine whether the concentrative nucleoside transport...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000094541

    authors: Gloeckner-Hofmann K,Guillén-Gómez E,Schmidtgen C,Porstmann R,Ziegler R,Stoss O,Casado FJ,Rüschoff J,Pastor-Anglada M

    更新日期:2006-01-01 00:00:00

  • Significance of vitamins in cancer.

    abstract::The relationship of vitamins to cancer is very complex. Three types of interactions are possible: the effect of vitamins on tumor growth, the effect of tumors on vitamin metabolism, and the effect of vitamins on chemical carcinogens and anti-tumor chemotherapeutic agents. The significance of vitamins with particular r...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000225139

    authors: Basu TK

    更新日期:1976-01-01 00:00:00

  • Plasma alpha-1-antitrypsin levels in early and late carcinoma of the cervix.

    abstract::Previous studies have demonstrated a rise in serum alpha-1-antitrypsin at advanced stages of malignancy. These, together with results of animal experiments with another anti-proteinase, aprotinin, have prompted studies of the plasma alpha-1-antitrypsin in the early stages of malignancy, using cervical carcinoma as a m...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225093

    authors: Latner AL,Turner GA,Lamin MM

    更新日期:1976-01-01 00:00:00

  • Docetaxel in patients with anthracycline-resistant advanced breast cancer.

    abstract:OBJECTIVE:To better determine docetaxel activity in patients with well-defined anthracycline-resistant breast cancer. METHODS:From October 1996, we carried out a phase II trial in 69 heavily pretreated patients with advanced breast cancer with docetaxel 100 mg/m(2) by a 1-hour infusion on day 1, with cycles repeated e...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000055298

    authors: Vici P,Belli F,Di Lauro L,Amodio A,Conti F,Foggi P,Gionfra T,Morelli MF,Botti C,Ferraironi A,Lopez M

    更新日期:2001-01-01 00:00:00

  • Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment.

    abstract::As the antitumor activity of radiation is mediated via its interaction with oxygen to form labile free radicals, the intratumoral oxygen level has an important influence on the ability of radiation therapy to kill malignant cells. By decreasing the oxygen-carrying capacity of the blood, anemia may result in tumor hypo...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000067147

    authors: Harrison LB,Shasha D,Homel P

    更新日期:2002-01-01 00:00:00

  • Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab.

    abstract:BACKGROUND:It is unclear for whom new anti-human epidermal growth factor receptor 2 (anti-HER2) agents, such as pertuzumab and T-DM1, should be considered. We investigated prognostic factors before neoadjuvant chemotherapy (NAC) among HER2-positive invasive breast cancer patients and those after NAC among patients who ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000502910

    authors: Fujita N,Enomoto Y,Inakami K,Yanagisawa T,Iguchi C,Aono T,Nomura T,Yamamoto H,Kasugai T,Shiba E

    更新日期:2020-01-01 00:00:00

  • Long-term follow-up of patients with advanced ovarian carcinoma treated with debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide. Gynecologic Oncology Group of the Comprehensive Cancer Center.

    abstract::Between June 1980 and December 1984, 88 patients with stage III-IV ovarian carcinoma were entered in a study evaluating the role of debulking surgery and chemotherapy consisting of cyclophosphamide, doxorubicin, and cisplatin intravenously on day 1, every 4 weeks (CAP-1). The results after a median follow-up of 62 mon...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226801

    authors: Wils JA

    更新日期:1990-01-01 00:00:00

  • A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide.

    abstract::From January 1991 to August 1993, 237 women with metastatic breast cancer were recruited into a multicentric phase II clinical trial designed to assess the cardioprotective activity of Cardioxane (ICRF-187). All patients were treated with 5-fluorouracil 500 mg/m2, doxorubicin 50 mg/m2, cyclophosphamide 500 mg/m2 (FDC)...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227467

    authors: Kolaric K,Bradamante V,Cervek J,Cieslinska A,Cisarz-Filipcak E,Denisov LE,Donat D,Drosik K,Gershanovic M,Hudziec P

    更新日期:1995-05-01 00:00:00

  • BK virus-induced tumors in hamsters: a morphological, histochemical and ultrastructural study.

    abstract::Macroscopic morphology, histology and ultrastructure of BK virus (BKV)-induced hamster and mouse tumors were investigated. Groups of animals were immunosuppressed to study the relationship between immune system and BKV oncogenesis. Ependymomas had the highest incidence, followed by tumors of pancreatic islets, osteosa...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225777

    authors: Altavilla G,Carrà L,Alberti S,Corallini A,Cavazzini L,Fabris G,Aleotti A,Barbanti-Brodano G

    更新日期:1983-01-01 00:00:00

  • Single, high-dose intravenous dexamethasone as an antiemetic in cancer chemotherapy.

    abstract::The antiemetic effect of graded, single high-dose intravenous dexamethasone was studied in 27 patients receiving combination chemotherapy with either doxorubicin (50 mg/m2) or cis-platinum (100 mg/m2). A total of 57 cycles were individually evaluated, utilizing a detailed rating system. Nausea and vomiting did not occ...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000226099

    authors: Zaglama NE,Rosenblum SL,Sartiano GP,Brady M,Gonzalez MF,Valdivieso JG

    更新日期:1986-01-01 00:00:00

  • A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.

    abstract:OBJECTIVE:The purpose of this study was to establish a new formula predicting liver metastasis in patients with colorectal cancer (CRC). METHODS:Nine previously reported predictive markers for liver metastasis and/or prognosis (COX-2, dysadherin, E-cadherin, beta-catenin, Ki-67, p53, laminin5gamma2, matrilysin and MUC...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151667

    authors: Ochiai H,Nakanishi Y,Fukasawa Y,Sato Y,Yoshimura K,Moriya Y,Kanai Y,Watanabe M,Hasegawa H,Kitagawa Y,Kitajima M,Hirohashi S

    更新日期:2008-01-01 00:00:00

  • Altered gene expression in rat colonic adenocarcinomas induced in an azoxymethane plus 2-amino-1-methyl-6-phenylimidazo[4,5-b]- pyridine initiation-promotion model.

    abstract::2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), the most abundant food-derived mutagenic/carcinogenic heterocyclic amine (HCA), has attracted particular attention as a probable human colon carcinogen. Some studies have shown that PhIP administered in the post-initiation phase is able to enhance rat colon carci...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000127423

    authors: Doi K,Hagihara A,Wei M,Yunoki T,Fukushima S,Wanibuchi H

    更新日期:2007-01-01 00:00:00

  • Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation.

    abstract:OBJECTIVE:The purpose of this study was to investigate the longitudinal changes in quality of life (QoL) for patients with advanced stage (stage III or IV) head and neck squamous cell carcinoma (HNSCC) following primary radiotherapy (RT) or concomitant chemoradiotherapy. METHODS:From January 2001 to January 2003, 149 ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000086982

    authors: Fang FM,Tsai WL,Chien CY,Chiu HC,Wang CJ,Chen HC,Hsiung CY

    更新日期:2005-01-01 00:00:00

  • A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors.

    abstract:PURPOSE:To determine the dose-limiting toxicities (DLTs) and the maximum-tolerated doses of the paclitaxel, oxaliplatin (LOHP) and capecitabine combination in patients with advanced solid tumors. PATIENTS AND METHODS:Patients received escalating doses of paclitaxel (starting dose 100 mg/m2) and LOHP (starting dose 40 ...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000111088

    authors: Saridaki Z,Bozionelou V,Kentepozidis N,Kotsakis A,Vardakis N,Kalykaki A,Gioulbasanis I,Karampeazis A,Vamvakas L,Georgoulias V,Mavroudis D

    更新日期:2007-01-01 00:00:00

  • Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma.

    abstract:BACKGROUND:The tumor suppressor gene p53 is a nuclear protein which plays a key role in tumor progression by regulating DNA repair, cell division and apoptosis. One major function of wild-type p53 is to control the onset of DNA replication at the G1-S boundary by inducing p21 protein, which promotes cell cycle arrest b...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000066223

    authors: Okuyama T,Maehara Y,Kabashima A,Takahashi I,Kakeji Y,Sugimachi K

    更新日期:2002-01-01 00:00:00

  • Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer.

    abstract:OBJECTIVES:Primary chemoradiotherapy for locally advanced pancreatic cancer (LAPC) may improve local control, curative resection rate and long-term survival. We performed a phase II study to evaluate toxicity and activity of primary radiation therapy and concurrent chemotherapy with gemcitabine (GEM) twice weekly in pa...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000086993

    authors: Magnino A,Gatti M,Massucco P,Sperti E,Faggiuolo R,Regge D,Capussotti L,Gabriele P,Aglietta M

    更新日期:2005-01-01 00:00:00

  • In vitro-in vivo correlation in anticancer drug sensitivity test using AUC-based concentrations and collagen gel droplet-embedded culture.

    abstract::To improve the ability of an in vitro drug sensitivity test to predict in vivo effects, we applied a drug concentration that was pharmacokinetically equivalent to plasma levels and collagen gel droplet-embedded culture with a high cloning efficiency. We reported that the cell-killing effect of cell cycle phase-nonspec...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227569

    authors: Inaba M,Tashiro T,Sato S,Ohnishi Y,Tanisaka K,Kobayashi H,Koezuka M

    更新日期:1996-05-01 00:00:00

  • Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade.

    abstract:BACKGROUND:Identification of high-risk stage II colorectal cancer (CRC) patients, potential candidates for adjuvant chemotherapy, is challenging. Current clinical guidelines rely mainly on histopathological markers with relatively weak prognostic value. This motivates further search for prognostic markers. METHODS:Thi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000507118

    authors: Dimberg J,Andersson RE,Haglund S

    更新日期:2020-01-01 00:00:00

  • Expression of stanniocalcin 1 as a potential biomarker of gastric cancer.

    abstract:OBJECTIVE:We investigated stanniocalcin 1 (STC 1) expression to assess its clinical utility as a blood marker in patients with gastric cancer and evaluated its biological impact in terms of tumor aggressiveness. METHODS:Blood specimens from 93 patients with gastric cancer and 21 normal healthy volunteers were assessed...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000341390

    authors: Arigami T,Uenosono Y,Ishigami S,Hagihara T,Haraguchi N,Matsushita D,Yanagita S,Nakajo A,Okumura H,Hokita S,Natsugoe S

    更新日期:2012-01-01 00:00:00

  • Targeted therapy in the treatment of metastatic renal cell cancer.

    abstract::The treatment of metastatic renal cell carcinoma (MRCC) has evolved from being predominantly cytokine-based to being grounded in the use of drugs targeting vascular endothelial growth factor, platelet-derived growth factor and mammalian target of rapamycin (mTOR) pathways. New agents including the small-molecule targe...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000258504

    authors: Di Lorenzo G,Scagliarini S,Di Napoli M,Scognamiglio F,Rizzo M,Carteni' G

    更新日期:2009-01-01 00:00:00

  • Hypoalbuminemia in patients receiving cisplatin: correlation between liver platinum and decrease in serum albumin.

    abstract::We evaluated changes in serum albumin concentrations in 15 patients with advanced malignancy who were also receiving cisplatin. All 15 patients had serial measurements of serum albumin. The decrease in serum albumin from the time of the first dose of cisplatin to death correlated with liver platinum levels at autopsy ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226100

    authors: Nanji AA,Mikhael NZ,Stewart DJ

    更新日期:1986-01-01 00:00:00

  • Pre- and postsurgery activation of blood coagulation in gastric and large bowel cancers: diagnostic, therapeutic and prognostic hints.

    abstract::In 12 patients with gastric cancer and in 14 with large bowel neoplasia, classified according to the TNM system, some major blood indices of hemostasis, platelet activation and fibrinolysis were assessed before and for 1 month after surgery, to show whether possible variations of such indices may provide useful clues ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226828

    authors: Abbasciano V,Guerra S,Reali MG,Guglielmini C

    更新日期:1990-01-01 00:00:00

  • Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questions.

    abstract::Breast cancer is the most common cancer in women. Although survival rates have improved with the use of new therapeutic agents, many issues remain unresolved and new predictive and prognostic factors are needed in clinical practice. Several studies have suggested a prognostic and predictive role for circulating and di...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000215581

    authors: Amadori A,Rossi E,Zamarchi R,Carli P,Pastorelli D,Jirillo A

    更新日期:2009-01-01 00:00:00